BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/21/2025 8:16:49 AM | Browse: 94 | Download: 0
Category |
Nutrition & Dietetics |
Manuscript Type |
Letter to the Editor |
Article Title |
Dose-dependent L-arginine cardiotoxicity in diabetic cardiomyopathy: Mechanisms and clinical implications
|
Manuscript Source |
Invited Manuscript |
All Author List |
Si-Jun Yang |
Funding Agency and Grant Number |
|
Corresponding Author |
Si-Jun Yang, Department of Laboratory Medicine, Huangshi Maternity and Children's Health Hospital, Affiliated Maternity and Children's Health Hospital of Hubei Polytechnic University, No. 9 Guilin South Road, Xialu District, Huangshi 435000, Hubei Province, China. yangsijun@ncu.edu.cn |
Key Words |
L-arginine; Type 2 diabetes; Myocardial injury; Oxidative stress; Inflammation |
Core Tip |
This letter critiques Mansouri et al's study on L-arginine (L-Arg) in diabetic cardiomyopathy, revealing dose-dependent cardiotoxicity: While low doses (0.5 g/kg) may modestly improve lipid profiles, higher doses (≥ 1 g/kg) exacerbate myocardial injury via prooxidant [nuclear factor E2-related factor (Nrf-2) depletion] and proinflammatory (inducible nitric oxide synthase-driven peroxynitrite) mechanisms. The findings challenge the perception of L-Arg as universally safe, especially in diabetics with endothelial dysfunction. Urgent clinical translation is needed to validate safe thresholds in humans, alongside tailored guidelines for vulnerable populations. Future research should prioritize human trials, combination therapies (e.g., Nrf-2 activators), and regulatory frameworks for supplement standardization. |
Citation |
Yang SJ. Dose-dependent L-arginine cardiotoxicity in diabetic cardiomyopathy: Mechanisms and clinical implications. World J Diabetes 2025; In press |
 |
Received |
|
2025-01-20 10:56 |
 |
Peer-Review Started |
|
2025-01-20 10:56 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-03-05 09:36 |
 |
Revised |
|
2025-03-12 11:52 |
 |
Second Decision |
|
2025-03-21 03:16 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-03-21 08:16 |
 |
Articles in Press |
|
2025-03-21 08:16 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2025-03-23 23:36 |
 |
Typeset the Manuscript |
|
2025-03-30 15:52 |
ISSN |
1948-9358 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345